Haemonetics（NYSE：HAE）報告季度每股收益為$1.19，高於分析師預期的$1.17，比預期高出1.71%。這是比去年同期每股收益$1.04增加了14.42%。公司報告季度銷售額為$3.49億，低於分析師預期的$3.5293億，低1.11%。這比去年同期的銷售額$3.3625億增加了3.79%。

以上內容來自Benzinga Earnings專欄，原文如下：

Haemonetics (NYSE:HAE) reported quarterly earnings of $1.19 per share which beat the analyst consensus estimate of $1.17 by 1.71 percent. This is a 14.42 percent increase over earnings of $1.04 per share from the same period last year. The company reported quarterly sales of $349.00 million which missed the analyst consensus estimate of $352.93 million by 1.11 percent. This is a 3.79 percent increase over sales of $336.25 million the same period last year.